vimarsana.com

Latest Breaking News On - Murali ramachandra - Page 1 : vimarsana.com

Breakthrough Kiwi cancer tech enters major deal with drug giant

Breakthrough NZ cancer therapy moves closer to market after deal with pharma giant.

New zealandNew zealand generalPeter laiMurali ramachandraChina hunan zhaotai medical groupMalaghan instituteWellington malaghan institute of medical researchWellington zhaotai therapiesand india basedMedical researchHunan zhaotai medical groupDavid downsZhaotai therapiesAurigene oncology

Dr Reddy s subsidiary Aurigene reports results of AUR101 in Phase II study in patients with moderate to severe psoriasis

There were no safety issues identified in the study. Aurigene will be closing the clinical development of AUR101 in psoriasis.

United statesMurali ramachandraReddy laboratories ltdAurigene oncologyChief executive officerLdr reddy

Aurigene reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis

Aurigene Oncology Ltd, a development stage biotechnology company today reported results of INDUS-3, a Phase 2b double blind placebo-controlled study of AUR101 conducted in the USA, in patients with moderate to severe psoriasis.

United statesMurali ramachandraReddy laboratories ltdAurigene oncology ltdReddy laboratoriesOncology ltdChief executive officerLaboratories limited

Olema Pharmaceuticals (OLMA), Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies

Olema Pharmaceuticals (OLMA), Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Seanp bohenMurali ramachandraAurigene discovery technologies limitedOlema pharmaceuticals incChief executive officer

Latest News | Dr Reddy s Arm Inks Pact with US-based Olema Pharmaceuticals

Get latest articles and stories on Latest News at LatestLY. Dr Reddy s Laboratories on Thursday said its subsidiary has inked a pact with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of an undisclosed oncology target. Latest News | Dr Reddy s Arm Inks Pact with US-based Olema Pharmaceuticals.

New delhiSeanp bohenMurali ramachandraOlema pharmaceuticals incAurigene discovery technologiesLinkedin expands its live audio featureChief executive officer

vimarsana © 2020. All Rights Reserved.